Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Bone Marrow Transplant. 2019 Jan 22;54(8):1337–1345. doi: 10.1038/s41409-019-0438-z

Table 3:

Factors associated with mortality

Multivariable Cox Regression Model for Mortality
N HR 95% CI p-value
Diagnosis/Phase
ALL CR1* 15 1.0 -- --
ALL CR2/Advanced 106 2.6 (1.4, 4.9) 0.002
AML CR1/MDS 48 2.2 (1.1, 4.3) 0.028
AML CR2/AML Advanced 63 2.9 (1.5, 5.4) 0.001
1st HCT Preparative Regimen
TBI-based 198 1.8 (1.0, 3.1) 0.052
Chemo-based* 23 1.0 -- --
RIC 11 4.1 (1.9, 9.1) <0.001
1st HCT to relapse (months)
0–6 114 3.2 (2.2, 4.7) <0.001
>6–12 66 2.1 (1.4, 3.2) <0.001
>12+ 52 1.0 -- --
*

Reference group

Note: Variables examined for potential inclusion in model were: Sex, Year of HCT, Time from HCT to relapse, Donor type, Diagnosis/Phase at HCT, Conditioning regimen, MRD status at relapse, Time from diagnosis to HCT, Age at HCT, Age at relapse.

Abbreviations: ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CHEMO, chemotherapy; CI, confidence interval; GVHD, graft-vs-host disease; HCT, hematopoietic cell transplant; HR, hazard ratio; IS, immune suppression; MDS, myelodysplastic syndrome; RIC, reduced intensity conditioning; TBI, total body irradiation.